{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:57:56Z","timestamp":1774871876437,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jinf.2019.12.005","type":"journal-article","created":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T20:39:10Z","timestamp":1576355950000},"page":"219-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hepatitis B virus-associated B-cell non-Hodgkin lymphoma in non-endemic areas in Western Europe: Clinical characteristics and prognosis"],"prefix":"10.1016","volume":"80","author":[{"given":"Marine","family":"Lemaitre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Brice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Frigeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Arcaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Besson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jinf.2019.12.005_bib0001","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/jvh.12391","article-title":"Risk of all-type cancer, hepatocellular carcinoma, non-Hodgkin lymphoma and pancreatic cancer in patients infected with hepatitis B virus","volume":"22","author":"Andersen","year":"2015","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.jinf.2019.12.005_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193232","article-title":"Chronic hepatitis B infection and non-hepatocellular cancers: a hospital registry-based, case-control study","volume":"13","author":"An","year":"2018","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jinf.2019.12.005_bib0003","first-page":"554","article-title":"High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma","volume":"91","author":"Marcucci","year":"2006","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.jinf.2019.12.005_bib0004","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/cncr.22549","article-title":"High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers","volume":"109","author":"Wang","year":"2007","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jinf.2019.12.005_bib0005","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1470-2045(10)70167-4","article-title":"Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study","volume":"11","author":"Engels","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jinf.2019.12.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-016-0073-x","article-title":"Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy","volume":"11","author":"Taborelli","year":"2016","journal-title":"Infect Agent Cancer"},{"issue":"8","key":"10.1016\/j.jinf.2019.12.005_bib0007","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00432-009-0551-2","article-title":"Medical history and risk of lymphoma: results of a European case\u2013control study (EPILYMPH)","volume":"135","author":"Becker","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.jinf.2019.12.005_bib0008","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.21642","article-title":"Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection","volume":"46","author":"Ulcickas Yood","year":"2007","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jinf.2019.12.005_bib0009","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1445-5994.2009.02060.x","article-title":"Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis: HBV and lymphoma","volume":"40","author":"Nath","year":"2010","journal-title":"Intern Med J"},{"issue":"12","key":"10.1016\/j.jinf.2019.12.005_bib0010","first-page":"22167","article-title":"Association of risk of non-Hodgkin's lymphoma with hepatitis B virus infection: a meta-analysis","volume":"8","author":"Qi","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"10.1016\/j.jinf.2019.12.005_bib0011","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ijc.31385","article-title":"Serologic markers of viral infection and risk of non-Hodgkin lymphoma: a pooled study of three prospective cohorts in China and Singapore: serologic markers of viral infection and risk of non-Hodgkin lymphoma","volume":"143","author":"Bassig","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jinf.2019.12.005_bib0012","article-title":"Hepatitis B virus and risk of non-Hodgkin lymphoma: an updated meta-analysis of 58 studies","author":"Li","year":"2018","journal-title":"J Viral Hepat"},{"issue":"4","key":"10.1016\/j.jinf.2019.12.005_bib0013","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.canep.2015.06.002","article-title":"Hepatitis B and C virus infection and risk of lymphoid malignancies: a population-based cohort study (JPHC study)","volume":"39","author":"Abe","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"9","key":"10.1016\/j.jinf.2019.12.005_bib0014","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.leukres.2013.06.007","article-title":"Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies","volume":"37","author":"Dalia","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.jinf.2019.12.005_bib0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2407-8-115","article-title":"Clinical and prognostic analysis of hepatitis b virus infection in diffuse large B-Cell lymphoma","volume":"8","author":"Wang","year":"2008","journal-title":"BMC Cancer"},{"issue":"24","key":"10.1016\/j.jinf.2019.12.005_bib0016","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2017-11-817601","article-title":"Genetic landscape of hepatitis b virus-associated diffuse large B-Cell lymphoma","volume":"131","author":"Ren","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jinf.2019.12.005_bib0017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3892\/etm.2013.1079","article-title":"Clinical analysis and prognostic significance of hepatitis b virus infections for diffuse large B-cell lymphoma with or without rituximab therapy","volume":"6","author":"Xie","year":"2013","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jinf.2019.12.005_bib0018","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.canep.2018.05.012","article-title":"HBV infection and extra-hepatic cancers in adolescents and 20s: a retrospective study in china","volume":"55","author":"Lu","year":"2018","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"10.1016\/j.jinf.2019.12.005_bib0019","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12072-017-9817-y","article-title":"Risk of hepatitis b reactivation in HBsAg-negative\/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis","volume":"11","author":"Tang","year":"2017","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.jinf.2019.12.005_bib0020","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.10.038","article-title":"American gastroenterological association institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Perrillo","year":"2015","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jinf.2019.12.005_bib0021","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jinf.2019.12.005_bib0022","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.23889","article-title":"Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 Lympho-c study: antiviral treatment in HCV-related NHL","volume":"90","author":"Michot","year":"2015","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.jinf.2019.12.005_bib0023","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.jinf.2019.12.005_bib0024","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s12185-008-0086-3","article-title":"Risk of malignant lymphoma following viral hepatitis infection","volume":"87","author":"Cocco","year":"2008","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.jinf.2019.12.005_bib0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1158\/1055-9965.EPI-10-0889","article-title":"et al. infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European prospective investigation into cancer and nutrition (EPIC)","volume":"20","author":"Franceschi","year":"2011","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"12","key":"10.1016\/j.jinf.2019.12.005_bib0026","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00432-012-1279-y","article-title":"Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case\u2013control study epilymph","volume":"138","author":"Becker","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.jinf.2019.12.005_bib0027","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00277-008-0469-9","article-title":"High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma","volume":"87","author":"Chen","year":"2008","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.jinf.2019.12.005_bib0028","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood-2010-06-275818","article-title":"Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities","volume":"117","author":"Marcucci","year":"2011","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.jinf.2019.12.005_bib0029","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.4677","article-title":"Hepatitis b virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis b surface antigen-driven origin","volume":"6","author":"Deng","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.jinf.2019.12.005_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129064","article-title":"Clinical analysis of the HBV infection status of 135 patients with diffuse large b cell lymphoma treated with r-chop or CHOP\/CHOP-Like chemotherapy","volume":"10","author":"Guo","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jinf.2019.12.005_bib0031","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-014-0845-3","article-title":"HBsAg is an independent prognostic factor in diffuse large b cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in china","volume":"31","author":"Wei","year":"2014","journal-title":"Med Oncol"},{"issue":"2","key":"10.1016\/j.jinf.2019.12.005_bib0032","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-0609.2007.00878.x","article-title":"The relationship of hepatitis b virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis","volume":"79","author":"Lim","year":"2007","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.jinf.2019.12.005_bib0033","first-page":"117","article-title":"The impact of hepatitis B virus (HBV) infection on clinical outcomes of patients with diffuse large B-cell lymphoma: impact of hepatitis B virus infection on patients with DLBCL","volume":"24","author":"Law","year":"2015","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"7","key":"10.1016\/j.jinf.2019.12.005_bib0034","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"et al. antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the fondazione Italiana linfomi","volume":"25","author":"Arcaini","year":"2014","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.jinf.2019.12.005_bib0035","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"et al. characteristics and outcome of diffuse large B-Cell lymphoma in hepatitis c virus\u2013positive patients in LNH 93 and LNH 98 groupe d'Etude des lymphomes de l'Adulte programs","volume":"24","author":"Besson","year":"2006","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jinf.2019.12.005_bib0036","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1182\/blood.V84.9.3047.3047","article-title":"Low-Grade malignant lymphoma, hepatitis c virus infection, and mixed cryoglobulinemia","volume":"84","author":"Pozzato","year":"1994","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jinf.2019.12.005_bib0037","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.7150\/jca.24384","article-title":"Capable infection of hepatitis B virus in diffuse large B-cell lymphoma","volume":"9","author":"Wang","year":"2018","journal-title":"J Cancer"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319303779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319303779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:28:29Z","timestamp":1759008509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445319303779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0163445319303779"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2019.12.005","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B virus-associated B-cell non-Hodgkin lymphoma in non-endemic areas in Western Europe: Clinical characteristics and prognosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2019.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}